Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Astragalus for Non-Motor Symptoms of α-Synucleinopathy
NCT05506891Phase 2Unknown
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Oct 2023
- Primary completion
- Jul 2024
- Modality
- Herbal supplement
- Countries
- 1
01
Overview
Phase 2, open-label trial of astrgalus in parkinsonism and orthostatic hypotension (OH) (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Change from baseline mean arterial pressure after 3 minutes of upright posture versus decubitus position. Status: unknown.
02
Drugs
astrgalus
03
Conditions
parkinsonismorthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT05506891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05506891.